| CB1 | cannabinoid receptor type 1 |
| CB2 | cannabinoid receptor type 2 |
| CNS | central nervous system |
| ECS | endocannabinoid system |
| AEA | anandamide |
| 2-AG | 2-arachidonoyl glycerol |
| NADA | N-arachidonoyl-dopamine |
| OAE | virodhamine |
| LPI | lysophosphatidylinositol |
| THC | delta-9 tetrahydrocannabinol |
| GPCRs | G-protein-coupled receptors |
| ECL | extracellular loop |
| ICL | intracellular loop |
| PKA | protein kinase A |
| WT | wild type |
| MI | myocardial infarction |
| I/R | ischemic/reperfusion |
| LPS | lipopolysaccharide |
| α-SMA | α-smooth muscle actin |
| SGAs | second-generation antipsychotics |
| DOX | doxorubicin |
| PRSW | preload-recruitable stroke work |
| ESPVR | end-systolic pressure–volume relation |
| TM | transmembrane |